We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Check what side effects people have reported when they have taken a medicine.
Information about the reproductive risks of taking valproate medicines and the measures in place to reduce potential harm.
Guidance for prescribing vets on the use of the cascade.
A guide to the legislation enabling drug services and others to supply take home naloxone without a prescription to save a life in an emergency.
Summary of the latest safety advice for medicines and medical device users
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
DHSC publications relating to COVID-19 treatments and clinical trials.
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).